Logo

Biotia: Barry Zeman, Don Goldmann, Steven Salzberg

Dec 10, 2019

Biotia has added Barry Zeman, Don Goldmann, and Steven Salzberg to its scientific and clinical advisory board. Zeman is chief strategy officer and vice chairman of inpatient psychiatric hospital organization Assurance Health System, as well as chief stategy officer of telehealth company MedSign. Goldmann is an epidemiologist at the Harvard T.H. Chan School of Public Health and CSO emeritus for the Institute for Healthcare Improvement, a Boston-based patient safety organization. Salzberg is director of the Center for Computational Biology in the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins University.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.